New antibody combo targets tough lymphoma in early trial
Disease control
Not yet recruiting
This study tests a new drug called EMB-07, a bispecific antibody that helps the immune system attack cancer cells. It is for adults with aggressive B-cell non-Hodgkin lymphoma, either newly diagnosed or that has returned after treatment. The trial will check safety, side effects,…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC